BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14678773)

  • 1. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23).
    Diez M; Danner S; Frey P; Sommer B; Staufenbiel M; Wiederhold KH; Hökfelt T
    Neurobiol Dis; 2003 Dec; 14(3):579-94. PubMed ID: 14678773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein--initial observations.
    Diez M; Koistinaho J; Kahn K; Games D; Hökfelt T
    Neuroscience; 2000; 100(2):259-86. PubMed ID: 11008166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.
    Kelley CM; Perez SE; Overk CR; Wynick D; Mufson EJ
    J Alzheimers Dis; 2011; 25(3):491-504. PubMed ID: 21471639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
    Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
    Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of Alzheimer's disease.
    Bornemann KD; Staufenbiel M
    Ann N Y Acad Sci; 2000 Jun; 908():260-6. PubMed ID: 10911965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Dec; 316(3):145-8. PubMed ID: 11744223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease.
    Lin J; Li X; Yuan F; Lin L; Cook CL; Rao ChV; Lei Z
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):253-61. PubMed ID: 20142765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
    Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C
    Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model.
    Sturchler-Pierrat C; Staufenbiel M
    Ann N Y Acad Sci; 2000; 920():134-9. PubMed ID: 11193142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice.
    Machová E; Rudajev V; Smycková H; Koivisto H; Tanila H; Dolezal V
    Neurobiol Dis; 2010 Apr; 38(1):27-35. PubMed ID: 20053373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.